Stem cell therapy in Turkey
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Türkiye is one of the few countries where cell therapy can be given lawfully outside a clinical trial, under Ministry of Health licensing of both the laboratory and the treating hospital. That legal position is the reason most international patients come — but it is a statement about regulation, not about proof. This page explains both sides honestly.
Why patients travel to Türkiye
In the United States, the European Union and the United Kingdom, cultured mesenchymal stromal cells are regulated as medicinal products. With almost no licensed products for the indications patients ask about, treatment there is generally only available inside a clinical trial. Türkiye regulates cell therapy through licensing and inspection of the production site and the treating centre, which allows lawful clinical use within the national framework.
The honest summary: travelling changes what is legally available to you. It does not change what the evidence shows. Read the evidence pillar before you read anything about protocols or prices.
| Market | Status of MSC therapy for most indications | What that means for you |
|---|---|---|
| United States (FDA) | No MSC product is licensed for the indications discussed here; cultured MSCs are regulated as drugs and require an IND | Treatment is available only inside a registered clinical trial |
| European Union (EMA) | Cultured MSCs are ATMPs; no centrally authorised product for these indications | Access is via trial or, in some member states, a hospital exemption |
| United Kingdom (MHRA) | Same ATMP framework; no licensed product for these indications | Trial access, or the Specials/hospital-exemption route |
| Türkiye (Ministry of Health) | Cell therapy is licensed and inspected at the level of the manufacturing site and the treating centre; clinical use is permitted within the national framework | Lawful treatment outside a trial is possible, which is why patients travel — legality is not the same as proven efficacy |
Why do international patients travel to Turkey for stem cell therapy?
Patients travel to Turkey because licensed centres can offer GMP-manufactured mesenchymal stem cell treatment at a fraction of United States or Western European prices, usually within weeks rather than months. Turkey regulates cell therapy through the Ministry of Health, so treatment is limited to licensed facilities and defined indications, and legality should be verified before booking.
Key facts
- Regulator
- Türkiye Ministry of Health, licensed centres only
- Typical stay
- 5 – 10 days for most protocols
- Cost position
- Commonly 40–70% below comparable US pricing
- Cell source used here
- Wharton's jelly MSCs, GMP-manufactured
What we know
- Turkey licenses cell-therapy centres and requires manufacture under GMP conditions.
- Short-term safety data for MSC administration is broadly reassuring across published human series.
What remains uncertain
- Efficacy evidence differs sharply by indication; several popular indications rest on early-phase data only.
- Cross-border follow-up quality depends on your home clinician's willingness to co-manage.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
What a treatment programme involves
- Records review — imaging, laboratory results and current medication are reviewed by a physician before anything is quoted. Not every enquiry is accepted.
- Cell source — most programmes use allogeneic Wharton's jelly MSCs from screened donated umbilical cord tissue. Why Wharton's jelly.
- Manufacturing — expansion and release testing in a licensed GMP facility. What GMP actually means.
- Release testing — viability, identity, sterility, endotoxin, mycoplasma and potency before any dose leaves the laboratory. Release criteria explained.
- Administration — intravenous, intrathecal or image-guided local injection depending on the indication, in a JCI-accredited hospital. The treating hospital.
- Follow-up — scheduled review at defined intervals with your own physician kept in the loop. Post-procedure instructions.
Cost, plainly
Programme pricing depends on cell dose, number of applications, route of administration and hospital days — not on how serious your condition is. Published ranges and what is included are on the cost pillar and the pricing page.
A price that is quoted before anyone has read your records is a warning sign, not a bargain.
How to check any Turkish clinic before you pay
Use the same checks on us that you use on everyone else. The full list is on the provider comparison pillar; the short version is below.
- Ask which entity holds the production licence and ask to see it.
- Ask for a sample certificate of analysis with viability, sterility, endotoxin and potency.
- Ask which hospital administers the cells and verify its accreditation independently.
- Ask for the name and licence of the physician who will treat you.
- Ask what happens if you are declined after the records review, and what is refundable.
- Walk away from any clinic that quotes a success rate or promises a cure. Mesenchymal stromal cell (MSC) therapy is not an approved treatment for these indications in the United States, the European Union or the United Kingdom. Nothing on this page is a promise of benefit.
Conditions people ask about most
Each condition pillar below opens with an "Evidence at a glance" panel stating whether human studies exist, whether randomised trials exist, and what role the treatment can honestly play.
Frequently asked questions
Is stem cell therapy legal in Turkey?
Yes, within the national framework: the manufacturing site and the treating centre are licensed and inspected by the Ministry of Health. Licensing details.
Is it approved for my condition?
For almost all indications discussed on this site, no regulator has approved MSC therapy as a treatment. Lawful availability in Türkiye is not the same as regulatory approval or proven efficacy. Status by country.
How long do I need to stay in Istanbul?
Most programmes run between three and ten days depending on the number of applications and the route of administration. Your itinerary is confirmed after the records review, not before. International patient guide.
What are the risks?
Reported reactions are mostly transient — fever, headache, injection-site pain. Serious events are uncommon in published series but the long-term safety profile is still being characterised. Safety pillar.
Read next
Have your records reviewed first
Whether any of this applies to you can only be decided after a physician reviews your medical records. The review is free and there is no obligation to travel.
Request a free medical review